Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Carcinogenesis

• Publication date

  1990-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CARCIN/11.8.1293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Exposure assessment and risk characterisation of aflatoxins in randomly collected rice samples from local markets of Hyderabad, India

  2024cites this paper
• How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?

  2020cites this paper
• Pharmacogenomics and Psychopharmacology

  2020cites this paper
• Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods.

  2019cites this paper
• The Effect on Oxidative Stress of Aflatoxin and Protective Effect of Lycopene on Aflatoxin Damage

  2017cites this paper
• Bioactivation and Regioselectivity of Pig Cytochrome P450 3A29 towards Aflatoxin B1

  2016cites this paper
• Metabolic detoxification pathways for 5-methoxy-sterigmatocystin in primary tracheal epithelial cells

  2014influential citation
• Neonatal Livers: A Source for the Isolation of Good-Performing Hepatocytes for Cell Transplantation

  2014cites this paper
• Sex and Strain Differences in Acute Hepatotoxic and Inflammatory Responses to Liver Procarcinogens in the Developing Mouse

  2013cites this paper
• Oxidation of methyl and ethyl nitrosamines by cytochrome P450 2E1 and 2B1.

  2012cites this paper
• Docking, molecular dynamics simulation studies, and structure-based QSAR model on cytochrome P450 2A6 inhibitors

  2012cites this paper
• CYP2A6: genetics, structure, regulation, and function

  2012cites this paper
• Age‐Dependent Expression of Human Drug‐Metabolizing Enzymes

  2012cites this paper
• Cytostatic drugs in infants: a review on pharmacokinetic data in infants.

  2012cites this paper
• Effect of Genetic Polymorphism of CYP2A6 on Individual Susceptibility to Colorectal Tumors in Japanese Smokers

  2012cites this paper
• Multi-step oxidations catalyzed by cytochrome P450 enzymes: Processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms.

  2011cites this paper
• LIVER TISSUE MODEL FOR DRUG TOXICITY SCREENING

  2011cites this paper
• Contribution of uniformly 13C-enriched sterigmatocystin to the study of its pulmonary metabolism.

  2011cites this paper
• Oxidation of N-Nitrosoalkylamines by Human Cytochrome P450 2A6

  2010cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cites this paper
• QSAR of cytochrome inhibitors

  2009cites this paper
• Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen.

  2008cites this paper
• CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives

  2008cites this paper
• The ontogeny of drug metabolism enzymes and implications for adverse drug events.

  2008cites this paper
• Molecular and Biochemical Mechanisms of Action of Acute Toxicity and Carcinogenicity Induced by Aflatoxin B1, and of the Chemoprevention of Liver Cancer

  2007cites this paper
• Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.

  2006cites this paper
• Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma.

  2006cites this paper
• Toxicity of Aflatoxin B1 to Helicoverpa zea and Bioactivation by Cytochrome P450 Monooxygenases

  2006cites this paper
• Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract

  2006cites this paper
• Inhibition of human cytochrome P450 2E1 by halogenated anilines, phenols, and thiophenols.

  2005cites this paper
• Threat assessment of mycotoxins as weapons: molecular mechanisms of acute toxicity.

  2005cites this paper
• Cytochromes P450 in the bioactivation of chemicals.

  2004cites this paper
• Decreasing smoking behaviour and risk through CYP2A6 inhibition.

  2003cites this paper
• Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

  2003cites this paper
• Quantitation of cytochrome P450 mRNA levels in human skin.

  2003cites this paper
• CREATION OF A BACTERIAL MUTAGENICITY ASSAY HIGHLY SENSITIVE TO DIALKYLNITROSAMINES

  2002cites this paper
• Entwicklung und Anwendung von Methoden zur Untersuchung der in vivo-Alkylierung in Abhängigkeit von der Tabakrauchexposition mit Hilfe unterschiedlicher Biomarker

  2002cites this paper
• CYP2A6 Activity Determined by Caffeine Phenotyping

  2002cites this paper
• CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

  2002cites this paper
• CYP2A6 genetic variation and potential consequences.

  2002cites this paper
• Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior

  2002cites this paper
• Genetic polymorphisms in drug-metabolizing enzymes and drug targets.

  2001cites this paper
• Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH–cytochrome P450 reductase

  2001cites this paper
• Predicting the mutagenicity of tobacco‐related N‐nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH–cytochrome P450 reductase

  2001cites this paper
• Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk.

  2001cites this paper
• The epidemiology of lung cancer.

  2001cites this paper
• Identification of a 43-kDa protein in human liver cytosol that binds to the 3'-untranslated region of CYP2A6 mRNA.

  2001cites this paper
• CYP2A6: a human coumarin 7-hydroxylase.

  2000cites this paper
• Genetic polymorphism of CYP2A6 in the German population.

  2000cites this paper
• Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

  2000cites this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cites this paper
• Practical application of mammalian cytochrome P450.

  2000cites this paper
• Mechanisms of Action of Aflatoxin B1 at the Biochemical and Molecular Levels

  2000cites this paper
• Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.

  2000cites this paper
• Significance of polymorphisms in CYP2A6 gene

  2000cites this paper
• Mimicking Gene Defects to Treat Drug Dependence

  2000cites this paper
• Advantage of the use of human liver S9 in the Ames test.

  1999cites this paper
• Characterization of cytochrome P450 expression in human oesophageal mucosa.

  1999cites this paper
• The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.

  1999cites this paper
• The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future.

  1999cites this paper
• Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.

  1999cites this paper
• Short Communication CYP2D6 Genotype and the Incidence of Anal and Vulvar Cancer 1

  1999cites this paper
• Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst.

  1999cites this paper
• A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.

  1999cites this paper
• CYP2D6 genotype and the incidence of anal and vulvar cancer.

  1999cites this paper
• A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.

  1999cites this paper
• Expression of CYP2A genes in human liver and extrahepatic tissues.

  1999cites this paper
• Nicotine metabolism variability and nicotine addiction.

  1999cites this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer

  1999cites this paper
• Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.

  1999cites this paper
• Molecular genetics of the human cytochrome P450 monooxygenase superfamily.

  1998cites this paper
• Genetic Polymorphism of Drug Metabolizing Enzymes: New Mutations in CYP2D6 and CYP2A6 Genes in Japanese

  1998cites this paper
• Genetically engineered cells stably expressing cytochrome P450 and their application to mutagen assays.

  1998cites this paper
• Single‐dose disulfiram does not inhibit CYP2A6 activity

  1998cites this paper
• Coumarin chemoprotection against aflatoxin B1‐induced gene mutation in a mammalian cell system: A species difference in mutagen activation and protection with chick embryo and rat liver S9

  1998cites this paper
• Activation of procarcinogens by human cytochrome P450 enzymes.

  1998cites this paper
• Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase

  1998cites this paper
• Cloning and Characterization of Syrian Hamster Testosterone 7α-Hydroxylase, CYP2A9

  1998cites this paper
• Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes.

  1997cites this paper
• Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system.

  1997cites this paper
• Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.

  1997cites this paper
• A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.

  1997cites this paper
• Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.

  1997cites this paper
• Nitrosamine carcinogenesis: rodent assays, quantitative structure-activity relationships, and human risk assessment.

  1997cites this paper
• Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.

  1997cites this paper
• Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions.

  1997cites this paper
• 18 – Drug Metabolism and Carcinogen Activation Studies with Human Genetically Engineered Cells

  1996cites this paper
• Distribution of 7-alkyl-2'-deoxyguanosine adduct levels in human lung.

  1996cites this paper
• In vitro metabolism of a rifamycin derivative by animal and human liver microsomes, whole blood and expressed human CYP3A isoform.

  1996cites this paper
• Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.

  1996cites this paper
• Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.

  1996cites this paper
• Human cytochrome P450's are pro-oxidants in iron/ascorbate-initiated microsomal lipid peroxidation.

  1996cites this paper
• Overexpression of Cytochrome P-450 Isoforms Involved in Aflatoxin B1 Bioactivation in Human Liver with Cirrhosis and Hepatitis

  1996cites this paper
• Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N,N-dimethylnitrosamine in cytotoxicity testing.

  1996cites this paper
• N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.

  1996cites this paper
• Human liver S‐9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/β‐naphthoflavone or Aroclor 1254 induced ratS‐9

  1996cites this paper
• S-酸化反応に関与するヒト肝P450分子種の同定: SM-12502を例として

  1995cites this paper
• The inhibition of CYP enzymes in mouse and human liver by pilocarpine

  1995cites this paper
• Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research

  1995cites this paper
• The Construction of Cell Cultures Genetically Engineered for Metabolic Competence towards Xenobiotics

  1995cites this paper